Index RUT
P/E 12.50
EPS (ttm) 0.85
Insider Own 13.08%
Shs Outstand 31.36M
Perf Week -2.08%
Market Cap 333.11M
Forward P/E 17.81
EPS next Y 0.59
Insider Trans -16.50%
Shs Float 27.33M
Perf Month -10.89%
Income 25.89M
PEG 0.83
EPS next Q 0.04
Inst Own 74.81%
Short Float 0.99%
Perf Quarter 13.56%
Sales 394.15M
P/S 0.85
EPS this Y 0.47%
Inst Trans 1.16%
Short Ratio 2.78
Perf Half Y 12.00%
Book/sh 5.23
P/B 2.03
EPS next Y 22.68%
ROA 8.14%
Short Interest 0.27M
Perf Year 64.52%
Cash/sh 2.22
P/C 4.77
EPS next 5Y 15.00%
ROE 17.28%
52W Range 5.99 - 13.05
Perf YTD 5.53%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI 8.77%
52W High -18.81%
Beta 1.40
Dividend TTM -
Quick Ratio 1.94
Sales past 5Y 7.58%
Gross Margin 57.58%
52W Low 76.73%
ATR (14) 0.43
Dividend Ex-Date Dec 11, 2014
Current Ratio 1.98
EPS Y/Y TTM 146.02%
Oper. Margin 1.93%
RSI (14) 39.46
Volatility 4.95% 3.37%
Employees 2300
Debt/Eq 0.87
Sales Y/Y TTM 11.65%
Profit Margin 6.57%
Recom 1.00
Target Price 14.75
Option/Short Yes / Yes
LT Debt/Eq 0.79
EPS Q/Q -97.22%
Payout 0.00%
Rel Volume 0.68
Prev Close 10.59
Sales Surprise 6.57%
EPS Surprise 194.00%
Sales Q/Q 18.42%
Earnings May 06 BMO
Avg Volume 97.15K
Price 10.60
SMA20 -6.40%
SMA50 -3.41%
SMA200 8.84%
Trades
Volume 21,043
Change 0.05%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-09-22 Initiated
Rosenblatt
Buy
$8
Jun-30-22 Initiated
Lake Street
Buy
$8
Sep-10-20 Initiated
Canaccord Genuity
Buy
$12
Jun-23-20 Initiated
Colliers Securities
Buy
$6
May-22-20 Initiated
B. Riley FBR
Buy
$4.50
Aug-29-12 Downgrade
Oppenheimer
Outperform → Perform
Mar-09-12 Reiterated
Wunderlich
Hold
$11 → $8
Sep-01-11 Initiated
Wunderlich
Hold
$11
Aug-04-11 Reiterated
Barclays Capital
Equal Weight
$14 → $11
Oct-21-10 Reiterated
Barclays Capital
Equal Weight
$22 → $19
Aug-06-10 Reiterated
Oppenheimer
Outperform
$31 → $21
Apr-09-10 Upgrade
Oppenheimer
Perform → Outperform
$31
Mar-04-10 Reiterated
Barrington Research
Outperform
$35 → $42
Jan-20-10 Initiated
Oppenheimer
Perform
Oct-02-09 Reiterated
Barclays Capital
Overweight
$29 → $30
Apr-24-09 Downgrade
Robert W. Baird
Outperform → Neutral
$20 → $17
Apr-21-09 Downgrade
Credit Suisse
Outperform → Neutral
Mar-06-09 Reiterated
Credit Suisse
Outperform
$18 → $19
Jan-12-09 Upgrade
BMO Capital Markets
Market Perform → Outperform
Sep-26-08 Initiated
Credit Suisse
Outperform
$18
Show Previous Ratings
Jun-12-24 09:00AM
03:33AM
Jun-04-24 08:30AM
May-30-24 12:00PM
May-29-24 06:44PM
08:50AM
Loading…
May-24-24 08:50AM
May-21-24 03:49PM
08:50AM
May-10-24 09:32AM
09:15AM
May-08-24 08:50AM
May-07-24 03:05PM
09:34AM
09:00AM
03:04AM
11:49PM
Loading…
May-06-24 11:49PM
(Thomson Reuters StreetEvents) +10.28%
03:12PM
12:52PM
12:52PM
09:15AM
08:07AM
08:00AM
May-05-24 03:00AM
May-03-24 08:30AM
May-01-24 01:44PM
Apr-25-24 11:27AM
Apr-23-24 12:30PM
Apr-18-24 03:35AM
Apr-17-24 03:40AM
Apr-16-24 08:30AM
05:54AM
Loading…
05:54AM
Apr-15-24 04:08AM
Apr-09-24 06:19AM
Mar-21-24 03:56PM
Mar-20-24 12:25PM
Mar-19-24 08:00AM
Mar-15-24 09:00AM
Mar-12-24 04:38PM
10:30AM
Mar-11-24 05:00PM
08:15AM
Mar-09-24 01:30AM
Mar-08-24 01:27AM
Mar-05-24 11:29PM
Feb-28-24 09:10AM
Feb-26-24 11:59PM
(Thomson Reuters StreetEvents) +5.34%
01:13PM
08:41AM
08:10AM
08:00AM
Feb-23-24 01:37PM
Feb-20-24 09:00AM
Feb-01-24 08:30AM
01:06AM
Jan-25-24 08:30AM
Nov-18-23 09:03AM
Nov-07-23 08:55AM
05:13AM
(Thomson Reuters StreetEvents)
Nov-06-23 01:12PM
08:00AM
Nov-03-23 12:12PM
Oct-27-23 11:23AM
Oct-05-23 11:40AM
08:50AM
Oct-04-23 08:30AM
Sep-19-23 09:00AM
Sep-12-23 09:15AM
Sep-05-23 12:45PM
Sep-04-23 09:15AM
Aug-31-23 11:40AM
08:50AM
Aug-24-23 08:30AM
Aug-23-23 08:30AM
Aug-21-23 12:20PM
Aug-16-23 12:00PM
Aug-15-23 02:21PM
Aug-10-23 12:57PM
Aug-08-23 12:40PM
12:05AM
(Thomson Reuters StreetEvents)
Aug-07-23 12:42PM
09:25AM
08:00AM
Aug-02-23 08:30AM
Aug-01-23 08:00AM
Jul-25-23 02:07PM
Jul-10-23 09:19AM
Jun-26-23 09:16AM
Jun-14-23 01:19PM
Jun-13-23 09:00AM
08:00AM
Jun-11-23 10:42AM
May-24-23 08:30AM
May-19-23 11:51AM
May-18-23 08:30AM
May-16-23 08:30AM
May-09-23 01:22AM
(Thomson Reuters StreetEvents)
May-08-23 09:15AM
08:00AM
May-02-23 09:00AM
Apr-24-23 12:55PM
Lincoln Educational Services Corp. engages in the provision of a career-oriented post-secondary education to recent high school graduates and working adults. It operates through the following segments: Campus Operations and Transitional. The Campus Operations segment includes campuses that are continuing in operation and contribute to the company's core operations and performance. The Transitional segment refers to businesses that are marked for closure and are currently being taught-out. The Corporate segment represents unallocated corporate activity. The company was founded in 1946 and is headquartered in Parsippany, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Juniper Investment Company, LL 10% Owner May 31 '24 Sale 11.75 25,010 293,775 246,299 Jun 04 04:00 PM Juniper Investment Company, LL 10% Owner May 21 '24 Sale 11.90 7,832 93,219 271,309 May 22 04:00 PM Juniper Investment Company, LL 10% Owner May 16 '24 Sale 12.00 5,841 70,115 279,141 May 17 04:01 PM Juniper Investment Company, LL 10% Owner May 15 '24 Sale 12.05 11,327 136,467 284,982 May 17 04:01 PM Juniper Investment Company, LL 10% Owner Mar 13 '24 Sale 10.00 8,055 80,552 296,309 Mar 13 04:41 PM Juniper Investment Company, LL 10% Owner Mar 12 '24 Sale 10.00 1,945 19,450 304,364 Mar 13 04:41 PM Juniper Investment Company, LL 10% Owner Mar 11 '24 Sale 9.97 12,844 128,055 956,223 Mar 11 04:58 PM Juniper Investment Company, LL 10% Owner Mar 08 '24 Sale 10.05 21,186 212,919 969,067 Mar 11 04:58 PM Nyce Chad D EVP & Chief Innovation Officer Mar 07 '24 Sale 10.02 26,000 260,520 154,646 Mar 08 06:55 PM BURKE JAMES J JR Director Mar 07 '24 Sale 10.24 11,225 114,944 88,671 Mar 11 03:01 PM Morrow J Barry Director Mar 07 '24 Sale 10.08 10,193 102,745 53,163 Mar 07 05:28 PM Juniper Investment Company, LL 10% Owner Mar 07 '24 Sale 10.03 6,558 65,777 990,253 Mar 11 04:58 PM Juniper Investment Company, LL 10% Owner Mar 06 '24 Sale 9.97 286,997 2,861,247 996,811 Mar 06 06:24 PM Morrow J Barry Director Mar 06 '24 Sale 10.04 22,610 227,004 63,356 Mar 07 05:28 PM Morrow J Barry Director Mar 05 '24 Sale 9.91 6,641 65,812 85,966 Mar 05 05:02 PM Morrow J Barry Director Mar 04 '24 Sale 9.95 9,193 91,470 92,607 Mar 05 05:02 PM Morrow J Barry Director Mar 01 '24 Sale 10.00 6,111 61,110 101,800 Mar 05 05:02 PM Juniper Investment Company, LL 10% Owner Feb 29 '24 Sale 10.09 73,241 739,002 1,293,390 Feb 29 08:45 PM Morrow J Barry Director Feb 29 '24 Sale 10.04 15,000 150,600 107,911 Feb 29 06:06 PM Juniper Investment Company, LL 10% Owner Feb 28 '24 Sale 10.22 70,000 715,400 1,366,631 Feb 29 08:45 PM Morrow J Barry Director Feb 28 '24 Sale 10.08 5,252 52,940 122,911 Feb 29 06:06 PM Juniper Investment Company, LL 10% Owner Feb 27 '24 Sale 10.13 169,592 1,717,967 1,436,631 Feb 29 08:45 PM BURKE JAMES J JR Director Nov 16 '23 Sale 9.60 494 4,742 99,926 Nov 17 05:12 PM BURKE JAMES J JR Director Nov 15 '23 Sale 9.61 3,942 37,883 100,420 Nov 17 05:12 PM BURKE JAMES J JR Director Nov 14 '23 Sale 9.63 3,773 36,334 120,365 Nov 15 04:23 PM BURKE JAMES J JR Director Nov 13 '23 Sale 9.60 788 7,565 124,138 Nov 15 04:23 PM Morrow J Barry Director Aug 15 '23 Sale 8.59 10,047 86,304 128,163 Aug 15 06:39 PM Morrow J Barry Director Aug 14 '23 Sale 8.69 12,000 104,280 138,210 Aug 15 06:39 PM Morrow J Barry Director Aug 11 '23 Sale 8.87 12,000 106,440 150,210 Aug 11 05:55 PM BURKE JAMES J JR Director Aug 10 '23 Sale 8.92 19,121 170,559 124,926 Aug 11 05:20 PM Morrow J Barry Director Aug 10 '23 Sale 8.86 12,000 106,320 162,210 Aug 11 05:55 PM BURKE JAMES J JR Director Aug 09 '23 Sale 8.93 20,879 186,449 144,047 Aug 11 05:20 PM Morrow J Barry Director Aug 09 '23 Sale 8.90 7,000 62,300 174,210 Aug 11 05:55 PM
Index -
P/E -
EPS (ttm) -0.34
Insider Own 42.81%
Shs Outstand 63.27M
Perf Week -3.55%
Market Cap 398.30M
Forward P/E 13.96
EPS next Y 0.45
Insider Trans -0.07%
Shs Float 36.22M
Perf Month -5.88%
Income -21.65M
PEG -
EPS next Q 0.07
Inst Own 33.32%
Short Float 1.63%
Perf Quarter 13.66%
Sales 522.74M
P/S 0.76
EPS this Y 1281.66%
Inst Trans 2.03%
Short Ratio 2.10
Perf Half Y 23.08%
Book/sh 2.69
P/B 2.32
EPS next Y 61.73%
ROA -2.57%
Short Interest 0.59M
Perf Year 71.43%
Cash/sh 0.39
P/C 15.82
EPS next 5Y -
ROE -12.03%
52W Range 2.70 - 7.04
Perf YTD 18.41%
Dividend Est. -
P/FCF 252.09
EPS past 5Y -51.10%
ROI -4.04%
52W High -11.36%
Beta 0.87
Dividend TTM -
Quick Ratio 0.97
Sales past 5Y 10.81%
Gross Margin 63.93%
52W Low 131.11%
ATR (14) 0.37
Dividend Ex-Date Mar 26, 2004
Current Ratio 1.53
EPS Y/Y TTM 92.57%
Oper. Margin 6.48%
RSI (14) 50.28
Volatility 5.63% 5.75%
Employees 970
Debt/Eq 2.36
Sales Y/Y TTM 1.72%
Profit Margin -4.14%
Recom 2.33
Target Price 8.50
Option/Short Yes / Yes
LT Debt/Eq 2.13
EPS Q/Q 96.78%
Payout -
Rel Volume 1.96
Prev Close 6.38
Sales Surprise 9.37%
EPS Surprise 204.95%
Sales Q/Q 8.73%
Earnings May 07 BMO
Avg Volume 282.24K
Price 6.24
SMA20 -4.78%
SMA50 13.78%
SMA200 36.90%
Trades
Volume 177,056
Change -2.19%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Upgrade
Canaccord Genuity
Hold → Buy
$7
Aug-09-23 Upgrade
Craig Hallum
Hold → Buy
$4 → $6
Nov-22-22 Downgrade
Craig Hallum
Buy → Hold
Nov-09-22 Downgrade
JP Morgan
Overweight → Underweight
Nov-09-22 Downgrade
Canaccord Genuity
Buy → Hold
$18 → $6
Mar-15-22 Initiated
Craig Hallum
Buy
$30
Nov-15-21 Resumed
Morgan Stanley
Overweight
$20
Nov-10-21 Resumed
JP Morgan
Overweight
$25
Jul-01-21 Downgrade
Goldman
Buy → Neutral
$20 → $19
Mar-08-21 Initiated
Morgan Stanley
Overweight
$18
Mar-08-21 Initiated
JP Morgan
Overweight
$17
Mar-08-21 Initiated
Goldman
Buy
$19
Mar-08-21 Initiated
Canaccord Genuity
Buy
$23
Show Previous Ratings
Jun-05-24 10:17AM
May-23-24 06:42AM
May-09-24 07:29AM
May-08-24 12:28PM
03:19AM
11:41PM
Loading…
May-07-24 11:41PM
(Thomson Reuters StreetEvents) +28.00%
07:00AM
Apr-29-24 07:30AM
Mar-13-24 08:48AM
Mar-12-24 10:20PM
(Thomson Reuters StreetEvents) +5.46%
09:11AM
07:30AM
Mar-04-24 08:00AM
Jan-18-24 04:15PM
Jan-12-24 04:15PM
04:30PM
Loading…
Dec-19-23 04:30PM
Dec-06-23 08:00AM
Nov-27-23 01:33AM
Nov-12-23 09:02AM
Nov-07-23 07:59AM
07:00AM
Oct-31-23 07:00AM
Oct-25-23 10:48AM
Sep-28-23 07:43AM
Sep-19-23 09:52PM
Sep-06-23 04:30PM
Aug-16-23 09:02AM
Aug-10-23 08:09AM
(American City Business Journals) +11.74%
Aug-08-23 10:02PM
(Thomson Reuters StreetEvents) +14.12%
07:30AM
08:30AM
Loading…
Aug-04-23 08:30AM
Aug-01-23 05:35PM
Jun-23-23 06:35PM
May-25-23 06:38AM
May-23-23 07:30AM
May-18-23 12:07PM
May-17-23 08:33AM
(Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM
May-15-23 05:33PM
May-11-23 07:00AM
May-10-23 09:00AM
May-03-23 08:30AM
Apr-08-23 08:55AM
Apr-05-23 10:52AM
08:00AM
07:38AM
Mar-31-23 07:30AM
07:00AM
Mar-30-23 04:51AM
Mar-29-23 08:55AM
Mar-20-23 10:16AM
Mar-16-23 08:30AM
Feb-28-23 07:30AM
Jan-27-23 02:49PM
(American City Business Journals)
Jan-14-23 03:14PM
Jan-04-23 07:00AM
Dec-27-22 02:53PM
(American City Business Journals)
Dec-09-22 11:58AM
(American City Business Journals)
Nov-28-22 10:34PM
(American City Business Journals) -20.41%
Nov-21-22 05:15PM
Nov-16-22 05:15PM
Nov-10-22 05:38AM
(Simply Wall St.) +25.58%
Nov-09-22 06:18PM
Nov-08-22 07:30AM
Oct-31-22 07:00AM
Oct-12-22 08:00AM
Aug-30-22 08:00AM
Aug-12-22 02:32AM
Aug-11-22 07:00AM
Aug-03-22 07:00AM
Jul-26-22 07:00AM
Jul-12-22 08:30AM
Jul-04-22 10:00AM
Jun-22-22 05:00AM
(American City Business Journals)
Jun-21-22 07:30AM
Jun-15-22 08:33AM
May-10-22 01:00PM
07:00AM
May-04-22 02:54PM
(American City Business Journals) -10.41%
05:56AM
May-03-22 05:47PM
01:57PM
May-02-22 07:00AM
Apr-26-22 02:59PM
(American City Business Journals)
09:05AM
08:38AM
Apr-25-22 07:00AM
Apr-08-22 09:15AM
Apr-07-22 10:12PM
Apr-05-22 07:00AM
Apr-04-22 05:36PM
02:23PM
(American City Business Journals)
11:27AM
07:00AM
Apr-03-22 09:10PM
Mar-25-22 07:32AM
(American City Business Journals)
Mar-16-22 07:00AM
Mar-11-22 09:43AM
Mar-10-22 12:30PM
07:00AM
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
STALNECKER SUSAN M Director Jun 07 '24 Option Exercise 0.00 30,400 0 79,464 Jun 11 08:46 PM SUTTER MARTIN P Director Jun 07 '24 Option Exercise 0.00 30,400 0 58,748 Jun 11 08:47 PM NEELS GUIDO J Director Jun 07 '24 Option Exercise 0.00 30,400 0 58,748 Jun 11 08:45 PM NOHRA GUY P Director Jun 07 '24 Option Exercise 0.00 30,400 0 100,117 Jun 11 08:46 PM Ladone Mary Kay Director Jun 07 '24 Option Exercise 0.00 30,400 0 50,674 Jun 11 08:44 PM HAWKINS WILLIAM A Director Jun 07 '24 Option Exercise 0.00 30,400 0 231,358 Jun 11 08:45 PM Beyer Pat Director Jun 07 '24 Option Exercise 0.00 30,400 0 48,978 Jun 11 08:43 PM McMurry-Heath Michelle Director Jun 07 '24 Option Exercise 0.00 30,400 0 47,819 Jun 11 08:44 PM Bartholdson John A. Director Jun 07 '24 Option Exercise 0.00 30,400 0 45,552 Jun 11 08:43 PM Bartholdson John A. Director Jun 06 '24 Option Exercise 0.00 7,576 0 15,152 Jun 10 05:40 PM Singleton Mark Leonard SVP & CFO Apr 11 '24 Sale 4.75 4,000 19,000 34,665 Apr 15 06:03 PM D'Adamio Anthony SVP & General Counsel Apr 11 '24 Sale 4.75 3,054 14,506 58,242 Apr 15 06:00 PM CHURCH KATRINA J SVP & Chief Compliance Officer Apr 11 '24 Sale 4.75 1,325 6,294 17,042 Apr 15 05:58 PM Singleton Mark Leonard SVP & CFO Mar 22 '24 Sale 5.39 5,541 29,853 25,665 Mar 25 05:36 PM D'Adamio Anthony SVP & General Counsel Mar 15 '24 Sale 5.46 3,125 17,062 51,371 Mar 20 06:41 PM CHURCH KATRINA J SVP & Chief Compliance Officer Mar 15 '24 Sale 5.46 1,217 6,645 14,067 Mar 20 06:41 PM Bihl Anthony P III Interim CEO Aug 18 '23 Buy 4.14 26,595 110,071 26,595 Aug 22 06:20 PM Bihl Anthony P III Interim CEO Aug 18 '23 Buy 4.14 13,290 55,005 138,290 Aug 22 06:20 PM Juniper Investment Company, LL 10% Owner Aug 14 '23 Buy 4.79 14,985 71,778 6,833,857 Aug 15 04:05 PM Bartholdson John A. Director Aug 14 '23 Buy 4.79 14,985 71,753 6,833,857 Aug 15 05:48 PM Bartholdson John A. Director Aug 11 '23 Buy 4.60 50,037 229,935 6,818,872 Aug 15 05:48 PM Juniper Investment Company, LL 10% Owner Aug 11 '23 Buy 4.56 50,037 228,169 6,818,872 Aug 15 04:05 PM Bartholdson John A. Director Aug 10 '23 Buy 4.47 111,848 500,419 6,768,835 Aug 14 06:04 PM Juniper Investment Company, LL 10% Owner Aug 10 '23 Buy 4.47 111,848 499,961 6,768,835 Aug 15 04:05 PM CHURCH KATRINA J SVP & Chief Compliance Officer Jul 03 '23 Sale 2.83 394 1,115 11,828 Jul 05 05:11 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite